Order Article Reprints

Mansour E, Palma AC, Ulaf RG, Ribeiro LC, Bernardes AF, Nunes TA, Agrela MV, Bombassaro B, Monfort-Pires M, Camargo RL, et al. Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19. Viruses. 2021; 13(2):309. https://doi.org/10.3390/v13020309

Mansour, Eli, Andre C. Palma, Raisa G. Ulaf, Luciana C. Ribeiro, Ana Flavia Bernardes, Thyago A. Nunes, Marcus V. Agrela, Bruna Bombassaro, Milena Monfort-Pires, Rafael L. Camargo, and et al. 2021. "Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19" Viruses 13, no. 2: 309. https://doi.org/10.3390/v13020309

Mansour, E., Palma, A. C., Ulaf, R. G., Ribeiro, L. C., Bernardes, A. F., Nunes, T. A., Agrela, M. V., Bombassaro, B., Monfort-Pires, M., Camargo, R. L., Araujo, E. P., Brunetti, N. S., Farias, A. S., Falcão, A. L. E., Santos, T. M., Trabasso, P., Dertkigil, R. P., Dertkigil, S. S., Moretti, M. L., & Velloso, L. A. (2021). Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19. Viruses, 13(2), 309. https://doi.org/10.3390/v13020309